Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Net Cash Flow (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Net Cash Flow of $10.6 million for Q1 2026, down 88.82% year-over-year from $94.4 million in Q1 2025, and down 87.5% quarter-over-quarter from $84.5 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Net Cash Flow (2022 - 2026) Analysis & Trends

Oculis Holding AG's Net Cash Flow history runs 5 years deep, the most recent figure standing at $10.6 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 88.82% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $56.0 million (down 40.7% YoY), while the FY2025 annual figure was $72.0 million, up 674.33% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $10.6 million, down from $84.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $94.4 million in Q1 2025, with the low at -$20.1 million in Q2 2025.
  • The 5-year median for Net Cash Flow is -$5.7 million (2022), against an average of $14.7 million.
  • The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 205.76% in 2023, then jumped 1030.89% in 2025.
  • Oculis Holding AG's Net Cash Flow stood at -$8.6 million in 2022, then surged by 219.38% to $10.3 million in 2023, then sank by 187.95% to -$9.1 million in 2024, then soared by 1030.89% to $84.5 million in 2025, then slumped by 87.5% to $10.6 million in 2026.
  • Business Quant data shows OCS's Net Cash Flow at $10.6 million in Q1 2026, $84.5 million in Q4 2025, and -$18.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - 6.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.07 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 84.47 Mn
Sep 30, 2025 -18.91 Mn
Jun 30, 2025 -20.10 Mn
Mar 31, 2025 94.39 Mn
Dec 31, 2024 -9.07 Mn
Sep 30, 2024 -13.33 Mn
Jun 30, 2024 22.47 Mn
Mar 31, 2024 -17.87 Mn
Dec 31, 2023 10.32 Mn
Sep 30, 2023 -17.36 Mn
Jun 30, 2023 22.52 Mn
Mar 31, 2023 86.12 Mn
Dec 31, 2022 -8.64 Mn
Sep 30, 2022 -5.68 Mn